Testing a new kidney disease treatment for young people with Alport syndrome

This study is testing a medication called dapagliflozin to see if it can help slow down kidney disease in teenagers and young adults who have Alport syndrome. Researchers have seen promising results with this medication in adults with other types of kidney disease, but it hasn't been thoroughly tested in younger patients yet. This trial will show whether adding this treatment to standard kidney disease medications can help protect kidney function and delay serious complications.

Young people with Alport syndrome often lose kidney function too quickly, eventually leading to kidney failure that requires dialysis or transplant. There is currently no proven treatment specifically designed to slow this progression in teenagers and young adults, so this medication could offer a much-needed new option to improve their long-term health and quality of life.